Internal ileal diversion as treatment for progressive familial intrahepatic cholestasis type 1-associated graft inflammation and steatosis after liver transplantation

HIGHLIGHTS

  • who: Anna M. Kavallar et al. from the Department of Paediatrics I, Medical University of Innsbruck, Innsbruck, Austria have published the research work: Internal Ileal Diversion as Treatment for Progressive Familial Intrahepatic Cholestasis Type 1-Associated Graft Inflammation and Steatosis after Liver Transplantation, in the Journal: Children 2022, 9, x FOR PEER REVIEW of /2022/
  • future: Future studies will explore the potential of IBAT inhibition.

SUMMARY

    As FIC1 is expressed in various tissues other than liver, PFIC1 patients might also present with hearing loss, pancreatitis, hypoparathyroidism and diarrhea. Of 10 However . . .

     

    Logo ScioWire Beta black

    If you want to have access to all the content you need to log in!

    Thanks :)

    If you don't have an account, you can create one here.

     

Scroll to Top

Add A Knowledge Base Question !

+ = Verify Human or Spambot ?